Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BYCureus

Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study

  • Faizudheen P1
  • Deepak K Saini2
  • Pooja Gunwal3
  • Shashikant Paswan4
  • Manisha B Thakur1
4 affiliations
  1. 1Department of Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IND
  2. 2Department of Orthopaedics, Maharishi Chyawan Government Medical College & Rao Tularam Hospital, Koriawas, IND
  3. 3Department of Anaesthesiology, Maharishi Chyawan Government Medical College & Rao Tularam Hospital, Koriawas, IND
  4. 4Department of Physical Medicine and Rehabilitation, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IND
Read full textPDFCite

Related

  1. Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study
    Vasileios Lekakis, Florence Wong, George Papatheodoridis +2
    Journal of Clinical and Experimental HepatologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  2. Association of a history of type 2 diabetes with short-term mortality in patients with decompensated cirrhosis.
    Honglei Ju, Guixiang Wang, Yujie Zhang +4
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  3. Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
    Yanting Ye, Zhiyin Huang, Jinhang Gao +1
    Journal of translational internal medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
  4. Clinical and patient-reported predictors of days alive and out of hospital in decompensated cirrhosis
    Sai Kiran Kuchana, Eric S. Orman, Kelly Mosesso +4
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Randomised, double-blind, placebo-controlled trial of faecal microbiota transplantation in patients with decompensated cirrhosis: the Livergut protocol.
    Adrià Juanola, Maria José Moreta, Cristina Solé +31
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{faizudheen2026plasma,
  title = {{Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study}},
  author = {Faizudheen P and Deepak K Saini and Pooja Gunwal and Shashikant Paswan and Manisha B Thakur},
  journal = {Cureus},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13676295},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study
AU  - Faizudheen P
AU  - Deepak K Saini
AU  - Pooja Gunwal
AU  - Shashikant Paswan
AU  - Manisha B Thakur
PY  - 2026
DA  - 2026/10/19
JO  - Cureus
UR  - https://europepmc.org/article/PMC/PMC13676295
SN  - 2168-8184
ER  -